A Patient-Centric Approach to Reforming the Prescription to Over-the-Counter Drug Pathway
January 23, 2026
AWHP highlights the critical role that nonprescription, over-the-counter drugs play in supporting the health of Americans nationwide in comments to a recent FDA RFI and a new white paper.
AWHP Response to FDA RFI on Nonprescription Drugs
January 22, 2026 - Food and Drug Administration (FDA)
AWHP recently submitted comments to a Request for Information from the FDA asking the public to share their perspectives on how to increase access to nonprescription drugs.
Urging Inclusion of the Sewell Act in the Year-End Healthcare Package (Senate)
January 22, 2026 - Senate Leadership
AWHP urged Senate Leadership to include the Sewell Act (S.339) in the final year-end healthcare package.
Urging Inclusion of the Sewell Act in the Year-End Healthcare Package (House)
January 22, 2026 - House Leadership
AWHP urged House Leadership to include the Sewell Act (H.R.842) in the final year-end healthcare package.
Urging Congress to Conduct Oversight of Changes to Vaccine Schedule
January 9, 2026 - American Academy of Pediatrics and Infectious Diseases Society of America
Appeal to Advisory Commission on Childhood Vaccines Ahead of Meeting
December 19, 2025 - Alliance for Aging Research
Prevention is Power: AWHP’s Path Forward in Women’s Preventive Health
December 16, 2025
AWHP is proud to present its 2025 End of Year Report sharing highlights from this year’s efforts.
Medicaid to stop covering weight-loss drugs for obesity in New Hampshire
December 9, 2025 - New Hampshire Bulletin
AWHP CEO Millicent Gorham discusses efforts urging New Hampshire to reconsider its decision to end Medicaid coverage of obesity medications.
Comments on Use of Pharmacotherapy to Address Obesity Among Nevada Medicaid Beneficiaries
December 8, 2025 - Nevada Health Authority
AWHP provided comment ahead of a public workshop on the use of pharmacotherapy to address obesity among Nevada Medicaid beneficiaries.